Condensed Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Stock-based compensation | $ 3,043 | $ 4,302 |
| Research and Development Expense | ||
| Stock-based compensation | 1,574 | 1,594 |
| Selling, General and Administrative Expenses | ||
| Stock-based compensation | $ 1,469 | $ 2,708 |